Clock-Modulating Activities of the Anti-Arrhythmic Drug Moricizine.
Ontology highlight
ABSTRACT: Dysregulated circadian functions contribute to various diseases, including cardiovascular disease. Much progress has been made on chronotherapeutic applications of drugs against cardiovascular disease (CVD); however, the direct effects of various medications on the circadian system are not well characterized. We previously conducted high-throughput chemical screening for clock modulators and identified an off-patent anti-arrhythmic drug, moricizine, as a clock-period lengthening compound. In Per2:LucSV reporter fibroblast cells, we showed that under both dexamethasone and forskolin synchronization, moricizine was able to increase the circadian period length, with greater effects seen with the former. Titration studies revealed a dose-dependent effect of moricizine to lengthen the period. I
SUBMITTER: Han C
PROVIDER: S-EPMC8293187 | biostudies-literature | 2021 Jun
REPOSITORIES: biostudies-literature
ACCESS DATA